Browsing by Author Carlino, Matteo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 45 < previous   next >
Issue DateTitleAuthor(s)Citation
2014Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanomaCarlino, Matteo; Fung, Carina; Howle, Julie; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Pupo, Gulietta; Rizos, Helen; Saw, Robyn; Scolyer, Richard; Shahheydari, Hamideh; Tembe, Varsha; Thompson, John; Hayward, Nicholas K; Hyman, Jessica; Johansson, Peter; Western Clinical School: Medicine (Westmead); Infectious Diseases; Western Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Surgery; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: SurgeryIncreased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma, Nature Communications, vol.5, N/A, 2014,pp 1-9
2014Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic MelanomaCarlino, Matteo; Carr, Peter; Haydu, Lauren; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Azer, Mary; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineInter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma, PloS One, vol.9, 1, 2014,pp 1-9
2016Ipilimumab combined with nivolumab: A standard of care for the treatment of advanced melanoma?Carlino, Matteo; Long, Georgina; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreIpilimumab combined with nivolumab: A standard of care for the treatment of advanced melanoma?, Clinical Cancer Research, vol.22, 16, 2016,pp 3992-3998
2016Ipilimumab combined with nivolumab: A standard of care for the treatment of advanced melanoma?Carlino, Matteo; Long, Georgina; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreIpilimumab combined with nivolumab: A standard of care for the treatment of advanced melanoma?, Clinical Cancer Research, vol.22, 16, 2016,pp 3992-3998
2016Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersCarlino, Matteo; Guminski, Alexander; Long, Georgina; Menzies, Alexander Maxwel; Buchbinder, Elizabeth I; et al, Various; Johnson, Douglas B; Khushalani, Nikhil I; Lawrence, Donald; Mudigonda, Tejaswi; Ott, Patrick A; Puzanov, Igor; Sullivan, Ryan; Ye, Fei; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineIpilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders, JAMA Oncology, vol.2, 2, 2016,pp 234-240
2015Ipilimumab-induced hypophysitis in melanoma patients: An Australian case seriesCarlino, Matteo; Chan, Matthew; Chipps, David; Chua, Elizabeth; Clements, Arthur; Kefford, Richard (Rick); Long, Georgina; Sweeting, Arianne; De Sousa, Sunita; Lam, T; Tonks, Katherine; Western Clinical School: Medicine (Westmead); Northern Clinical School: Melanoma Institute of Australia; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; School of Public Health: Public HealthIpilimumab-induced hypophysitis in melanoma patients: An Australian case series, Internal Medicine Journal, vol.45, 10, 2015,pp 1066-1073
2015Multiple gastrointestinal polyps in patients treated with BRAF inhibitorsCarlino, Matteo; Long, Georgina; Amaravadi, Ravi; Del Portillo, Armando; et al, Various; Hamilton, Kathryn E; Ma, Xiaohong; Morrissette, Jennifer J D; Nathanson, Katherine L.; Piao, Shengfu; Puzanov, Igor; Tsai, Kenneth Y; Xu, X; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreMultiple gastrointestinal polyps in patients treated with BRAF inhibitors, Clinical Cancer Research, vol.21, 23, 2015,pp 5215-5221
2017Negative immune checkpoint regulation by VISTA: A mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patientsCarlino, Matteo; Gide, Tuba; Jackett, Louise; Kakavand, Hojabr; Long, Georgina; Menzies, Alexander Maxwel; Saw, Robyn; Scolyer, Richard; Thompson, John; Wilmott, James; Westmead Clinical School: Medicine; Physiology; Central Clinical School: Medicine; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryNegative immune checkpoint regulation by VISTA: A mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients, Modern Pathology, vol.30, 12, 2017,pp 1666-1676
2016An Online Learning Module to Increase Self-Efficacy and Involvement in Care for Patients With Advanced Lung Cancer: Research ProtocolJanssen, Anna; Shaw, Timothy (Tim); Birnbaum, Robert; Carlino, Matteo; Gandhi, Tejal; Harnett, Paul; Nagrial, Adnan; Pene, Christopher; Phillips, Jane; Rabbets, Melanie; Zachulski, Clare; Health Sciences; Health SciencesAn Online Learning Module to Increase Self-Efficacy and Involvement in Care for Patients With Advanced Lung Cancer: Research Protocol, JMIR Research Protocols, vol.5, 3, 2016,pp 1-8
2017Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaCarlino, Matteo; Long, Georgina; Chiarion-Sileni, Vanna; Cowey, C; et al, Various; Gonzalez, Rene; Grob, Jean-Jacques; Lao, Christopher; Rutkowski, Piotr; Schadendorf, Dirk; Wagstaff, John; Wolchok, Jedd D.; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicineOverall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma, New England Journal of Medicine, vol.377, 14, 2017,pp 1345-1356
2016PD-1 and PD-L1 inhibitors in melanoma treatment: Past success, present application and future challengesCarlino, Matteo; Kefford, Richard (Rick); Lee, Jenny; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical ResPD-1 and PD-L1 inhibitors in melanoma treatment: Past success, present application and future challenges, Immunotherapy, vol.8, 6, 2016,pp 733-746
2017PD-L1 expression and immune escape in melanoma resistance to MAPK inhibitorsCarlino, Matteo; Howle, Julie; Kakavand, Hojabr; Long, Georgina; Menzies, Alexander Maxwel; Pupo, Gulietta; Saw, Robyn; Scolyer, Richard; Thompson, John; Wilmott, James; Yang, Jean Yee Hwa; Kefford, Richard; Rawson, Robert; Rizos, Helen; Westmead Clinical School: Medicine; Westmead Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Westmead Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: Surgery; Mathematics & StatisticsPD-L1 expression and immune escape in melanoma resistance to MAPK inhibitors, Clinical Cancer Research, vol.23, 20, 2017,pp 6054-6061
2017Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)Carlino, Matteo; Long, Georgina; Arance, A; Daud, Adil; et al, Various; Grob, Jean Jacques; Larkin, James; Lotem, Michal; McNeil, Catriona M.; Mortier, Laurent; Ribas, Antoni; Schachter, Jacob; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicinePembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006), The Lancet, vol.390, 10105, 2017,pp 1853-1862
2015Pembrolizumab versus ipilimumab in advanced melanomaCarlino, Matteo; Long, Georgina; Arance, Ana; Daud, Adil; et al, Various; Grob, Jean Jacques; Larkin, James; Lorigan, Paul; Lotem, Michal; McNeil, Catriona; Mortier, Laurent; Neyns, Bart; Robert, Caroline; Schachter, Jacob; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentrePembrolizumab versus ipilimumab in advanced melanoma, The New England Journal of Medicine, vol.372, 26, 2015,pp 2521-2532
2017Pharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysisBoddy, Alan; Carlino, Matteo; Harris, David; Lee, Vincent; Liu, Xiao man; Kefford, Richard; Park, J; Pharmacy; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); PharmacyPharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysis, Pigment Cell & Melanoma Research, vol.30, 1, 2017,pp 68-71
2017Phase I dose-escalation and -expansion study of the BRAF inhibitor encorafenib (LGX818) in metastatic BRAF-mutant melanomaCarlino, Matteo; Kefford, Richard (Rick); Arance, Ana; Delord, Jean-Pierre; et al, Various; Kudchakar, Ragini; Mahipal, Amit; McArthur, Grant A.; Nyakas, Marta; Robert, Caroline; Sullivan, Ryan; Yamada, Yasuhide; Westmead Clinical School: Medicine; Westmead Clinical School: MedicinePhase I dose-escalation and -expansion study of the BRAF inhibitor encorafenib (LGX818) in metastatic BRAF-mutant melanoma, Clinical Cancer Research, vol.23, 18, 2017,pp 5339-5348
2014Pre-existing MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patientsCarlino, Matteo; Fung, Carina; Kefford, Richard (Rick); Long, Georgina; Rizos, Helen; Scolyer, Richard; Todd, Jason; Boyd, Suzanah C; Irvine, Mal; Nagrial, Adnan; Shahheydari, Hamideh; Western Clinical School: Medicine (Westmead); Infectious Diseases; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Western Clinical School: Westmead Millennium InstitutePre-existing MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients, Clinical Cancer Research, vol.21, 1, 2014,pp 98-105
2017Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapyCarlino, Matteo; Long, Georgina; Menzies, Alexander Maxwel; Kapoor, Rony; Lorens, Shirleen; Sidhu, Parveen; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: MedicineRadiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy, Journal of Medical Imaging and Radiation Oncology, vol.61, 6, 2017,pp 759-766
2017Radiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapyCarlino, Matteo; Long, Georgina; Menzies, Alexander Maxwel; Kapoor, Rony; Lorens, Shirleen; Sidhu, Parveen; Westmead Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: MedicineRadiological manifestations of immune-related adverse effects observed in patients with melanoma undergoing immunotherapy, Journal of Medical Imaging and Radiation Oncology, vol.61, 6, 2017,pp 759-766
2016Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapyCarlino, Matteo; Guminski, Alexander; Kong, Benjamin; Long, Georgina; Menzies, Alexander Maxwel; Kefford, Richard F.; Liniker, Elizabeth; Ramanujam, Sangeetha; Saunders, Catherine A B; Western Clinical School: Medicine (Westmead); Medicine Faculty Office; Central Clinical School: Office; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineResidual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy, Pigment Cell & Melanoma Research, vol.29, 5, 2016,pp 572-577